Novo Holdings co-leads €40m Qure.ai fina...Deep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad more ➔
Sanofi and IGM Biosciences Inc. in $6.15bn...Sanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM $6bn if all milestones are met. more ➔
XNK Therapeutics AB raises €12.75mXNK Therapeutics AB has secured a private placement of €12.75m led by Flerie Invest AB to finance Phase II development of CellProtect + Isatuximab in multiple myeloma. more ➔
CSL Behring files for MAA of haemophilia B...CSL Behring has filed for accelerated approval of the first hemophilia B gene therapy in Europe. more ➔
Argenx SE to raise €637mDutch autoimmunity specialist Argenx SE has raised $700m to prepare commercialisation of subcutanous efgartigimod as treatment for generalized myasthenia gravis. more ➔
Bayer invests into synthetic TCRs for cell...TCR-T cell therapy specialist Affini-T Therapeutics Inc. (Seattle, Boston) has raised $175m Series A fnancing co-Led by Vida Ventures and Leaps by Bayer more ➔
Bavarian Nordic bags $225m for licence to...Bavarian Nordic is to receive up to US$225 and double-digit royalties for granting exclusive Chinese commercialisation rights for MVA-BN® RSV to Nuance Pharma. more ➔
Switzerland paves the way for genome editi...Switzerland is keeping its moratorium on GMO cultivation until 2025, but paving the way for exceptions in precision breeding. more ➔
Gilde Healthcare Private Equity IV launche...Gilde Healthcare Private Equity IV (GHPE IV) has closed at €517m for investments in proifitable healthcare companies in the lower mid-market in North-west Europe. more ➔
Precirix NV raises €80m in Series B fina...With €80m from a Series B financing in its pocket, Belgian Precirix NV plans to advance its pipeline of precision radiopharmaceuticals. more ➔
